We research, develop, and manufacture a broad range of generic pharmaceuticals.
We manufacture and market a diverse product range of generic pharmaceuticals, including limited competition, complex technology, niche and high volume products for treating a wide range of disease areas. Therapeutic areas include cardiovascular, central nervous system and pain management.
Find a Eywa Pharma Product
Search our catalog
Acetaminophen and Codeine Phosphate Tablets, USP
Equivalent to: Acetaminophen and Codeine Phosphate Tablets USP, 300 mg/15 mg
NDC: 71930-054-52 / 71930-054-12
Therapeutic Category: Narcotic Analgesic/Antitussive
Acetaminophen and Codeine Phosphate Tablets, USP
Equivalent to: Tylenol® with Codeine, 300 mg/30 mg
NDC: 71930-055-12 / 71930-055-52
Therapeutic Category: Narcotic Analgesic/Antitussive
Acetaminophen and Codeine Phosphate Tablets, USP
Equivalent to: Acetaminophen and Codeine Phosphate Tablets USP, 300 mg/60 mg
NDC: 71930-056-12 / 71930-056-52
Therapeutic Category: Narcotic Analgesic/Antitussive
Acetazolamide Tablets, USP
Therapeutic Category: Carbonic Anhydrase Inhibitor
Acetazolamide Tablets, USP
Therapeutic Category: Carbonic Anhydrase Inhibitor
Therapeutic Category: Muscle Relaxant/Antispastic
Package: 100 ct / 1000 ct
NDC: 71930-006-12 / 71930-006-13
Therapeutic Category: Muscle Relaxant/Antispastic
Package: 100 ct / 1000 ct
NDC: 71930-007-12 / 71930-007-13
Therapeutic Category: Muscle Relaxant/Antispastic
Brompheniramine Maleate, Pseudoephedrine Hydrochloride, and Dextromethorphan Hydrobromide Syrup
Strength: 2 mg/30 mg/10 mg per 5 mL
Equivalent to: Dimetane-DX Syrup
Therapeutic Category: Antihistamine/Nasal Decongestant/Antitussive
Carbamazepine Extended-release Tablets, USP
Equivalent to: Tegretol® - XR
Therapeutic Category: Anticonvulsant
Carbamazepine Extended-release Tablets, USP
Equivalent to: Tegretol® - XR
Therapeutic Category: Anticonvulsant
Carbamazepine Extended-release Tablets, USP
Equivalent to: Tegretol® - XR
Therapeutic Category: Anticonvulsant
Hydrocodone Bitartrate and Acetaminophen Oral Solution
Strength: 7.5 mg/325 mg per 15 mL
Equivalent to: Hydrocodone Bitartrate and Acetaminophen Oral Solution
Therapeutic Category: Opioid Analgesic
Hydrocodone Bitartrate and Acetaminophen Tablets, USP
Equivalent to: Hydrocodone Bitartrate and Acetaminophen Tablets, USP
NDC: 71930-042-12 / 71930-042-52
Therapeutic Category: Opioid Analgesic
Hydrocodone Bitartrate and Acetaminophen Tablets, USP
Equivalent to: Hydrocodone Bitartrate and Acetaminophen Tablets, USP
NDC: 71930-043-52 / 71930-043-12
Therapeutic Category: Opioid Analgesic
Hydrocodone Bitartrate and Acetaminophen Tablets, USP
Equivalent to: Hydrocodone Bitartrate and Acetaminophen Tablets, USP
NDC: 71930-044-12 / 71930-044-52
Therapeutic Category: Opioid Analgesic
Hydrocodone Bitartrate and Acetaminophen Tablets, USP
NDC: 71930-019-12 / 71930-019-52
Therapeutic Category: Opioid Analgesic
Hydrocodone Bitartrate and Acetaminophen Tablets, USP
NDC: 71930-020-12 / 71930-020-52
Therapeutic Category: Opioid Analgesic
Hydrocodone Bitartrate and Acetaminophen Tablets, USP
NDC: 71930-021-12 / 71930-021-52
Therapeutic Category: Opioid Analgesic
Labetalol Hydrochloride Tablets, USP
NDC: 71930-035-12 / 71930-035-52
Therapeutic Category: Adrenergic Receptor Blocking Agent
Labetalol Hydrochloride Tablets, USP
NDC: 71930-036-12 / 71930-036-52
Therapeutic Category: Adrenergic Receptor Blocking Agent
Labetalol Hydrochloride Tablets, USP
NDC: 71930-037-12 / 71930-037-52
Therapeutic Category: Adrenergic Receptor Blocking Agent
Levetiracetam Tablets, USP
Therapeutic Category: Antiepileptic
Levetiracetam Tablets, USP
NDC: 71930-063-15 / 71930-063-52
Therapeutic Category: Antiepileptic
Levetiracetam Tablets, USP
Therapeutic Category: Antiepileptic
Levetiracetam Tablets, USP
Therapeutic Category: Antiepileptic
Methylphenidate Hydrochloride Oral Solution
Equivalent to: Methylin® Oral Solution
Therapeutic Category: Central Nervous System Stimulant
Methylphenidate Hydrochloride Oral Solution
Equivalent to: Methylin® Oral Solution
Therapeutic Category: Central Nervous System Stimulant
NDC: 71930-017-30 / 71930-017-52
Therapeutic Category: Antimetic
NDC: 71930-018-30 / 71930-018-52
Therapeutic Category: Antimetic
Oxybutynin Chloride Tablets, USP
Package: 100 ct / 500 ct / 1000 ct
NDC: 71930-051-12 / 71930-051-52 / 71930-051-13
Therapeutic Category: Antispasmodic/Anticholinergic
Oxycodone Hydrochloride Oral Solution, USP
Strength: 5 mg/5 mL (1 mg/mL)
Equivalent to: Oxycodone Hydrochloride Oral Solution, USP
Therapeutic Category: Opioid Agonist
Oxycodone Hydrochloride Oral Solution, USP
Strength: 100 mg/5 mL (20 mg/mL)
Equivalent to: Oxycodone Hydrochloride Oral Solution, USP
Therapeutic Category: Opioid Agonist
Oxycodone and Acetaminophen Tablets, USP
NDC: 71930-045-12 / 71930-045-52
Therapeutic Category: Opioid Analgesic
Oxycodone and Acetaminophen Tablets, USP
NDC: 71930-046-12 / 71930-046-52
Therapeutic Category: Opioid Analgesic
Oxycodone and Acetaminophen Tablets, USP
NDC: 71930-047-12 / 71930-047-52
Therapeutic Category: Opioid Analgesic
Potassium Citrate Extended-release Tablets, USP
Therapeutic Category: Urinary Alkalinizing Agents
Potassium Citrate Extended-release Tablets, USP
Therapeutic Category: Urinary Alkalinizing Agents
Pyridostigmine Bromide Tablets, USP
Therapeutic Category: Cholinesterase Inhibitor
Therapeutic Category: Bile Acid
Valproic Acid Capsules, USP
Therapeutic Category: Antiepileptic
Product Question?
Questions, comments or concerns about Eywa Pharma Inc.'s products? Contact one of our trusted professionals today.
(888) 400-7422
Download Product Catalog